BusinessLegalPipelineResearchEventsProducts
Browse All Stories »
FEATURED
FDA approves Tenpoint's YUVEZZI as first dual-agent presbyopia drop

FDA approves Tenpoint's YUVEZZI as first dual-agent presbyopia drop

First and only combination drop of carbachol and brimonidine tartrate achieves miosis within 30 minutes and lasts up to 10 hours following once-daily dosing.

Earn FREE CE 24/7 with Courses by Eyes On Eyecare

Check it out

Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.

TRENDING
Videos
New QLOSI safety data supports drop as pupil selective for presbyopia
New QLOSI safety data supports drop as pupil selective for presbyopia
Scope's OPTASE HYLO Forte Dry Eye Drops offer long-lasting symptom relief
Scope's OPTASE HYLO Forte Dry Eye Drops offer long-lasting symptom relief
iOR Partners launches MD-OD surgery partnership model
iOR Partners launches MD-OD surgery partnership model
New 5-year Syfovre data indicates extended delay of GA progression
New 5-year Syfovre data indicates extended delay of GA progression
Watch More
Business
CSI Dry Eye Innovations unveils new branding and software patent
CSI Dry Eye Innovations unveils new branding and software patent
Leadership watch: Emmecell, ABO, Outlook, and Heidelberg make changes
Leadership watch: Emmecell, ABO, Outlook, and Heidelberg make changes
Leadership watch: OKYO, Orbis, and BVI Medical name new CEOs
Leadership watch: OKYO, Orbis, and BVI Medical name new CEOs
Newton names ABB Labs as strategic lab partner
Newton names ABB Labs as strategic lab partner
Read More
Research
First real-world data shows early promise of high-dose aflibercept for wet AMD
First real-world data shows early promise of high-dose aflibercept for wet AMD
Study demonstrates accuracy of new platform for comparing AI-based DR screening systems
Study demonstrates accuracy of new platform for comparing AI-based DR screening systems
Pseudoexfoliation glaucoma is most prevalent among Indigenous populations in the US
Pseudoexfoliation glaucoma is most prevalent among Indigenous populations in the US
Cannabis implicated in ocular inflammatory disease development
Cannabis implicated in ocular inflammatory disease development
Read More
Pipeline
FDA grants Fast Track designation for Drug Farm's ROSAH syndrome asset
FDA grants Fast Track designation for Drug Farm's ROSAH syndrome asset
FDA clears Novaliq's IND for NIAU phase 2 trial
FDA clears Novaliq's IND for NIAU phase 2 trial
Novartis's ianalumab earns FDA Breakthrough Therapy designation for Sjögren’s disease
Novartis's ianalumab earns FDA Breakthrough Therapy designation for Sjögren’s disease
FDA grants Orphan Drug designation to BlueRock's RP cell therapy
FDA grants Orphan Drug designation to BlueRock's RP cell therapy
Read More
Products
Automated vision-testing kiosks face concerns amid national expansion
Automated vision-testing kiosks face concerns amid national expansion
FDA approves Tenpoint's YUVEZZI as first dual-agent presbyopia drop
FDA approves Tenpoint's YUVEZZI as first dual-agent presbyopia drop
FDA approves Glaukos' iDose TR for repeat treatment labeling
FDA approves Glaukos' iDose TR for repeat treatment labeling
FDA approves Alembic's difluprednate 0.05% generic
FDA approves Alembic's difluprednate 0.05% generic
Read More
Legal
VA optometrists secure physician-level pay parity
VA optometrists secure physician-level pay parity
The Vision Council calls for optical product exemption from new tariffs
The Vision Council calls for optical product exemption from new tariffs
Regeneron settles with Sandoz over Eylea biosimilar patent infringement lawsuit
Regeneron settles with Sandoz over Eylea biosimilar patent infringement lawsuit
FDA issues Scope Health warning letter over OPTASE ophthalmic products
FDA issues Scope Health warning letter over OPTASE ophthalmic products
Read More
Archives
Hello 2023 — Weekly Glance
Hello 2023 — Weekly Glance
Can we treat uveitis without steroids? — Weekly Glance
Can we treat uveitis without steroids? — Weekly Glance
Can I have one dilation drop instead of two? — Weekly Glance
Can I have one dilation drop instead of two? — Weekly Glance
Are those dilation reversal drops available yet? — Weekly Glance
Are those dilation reversal drops available yet? — Weekly Glance
Read More
Events
Registration now open for Eyes On Dry Eye 2026
Registration now open for Eyes On Dry Eye 2026
Registration opens for the American Retina Forum with Eyes On Eyecare 2026
Registration opens for the American Retina Forum with Eyes On Eyecare 2026
Happy New Year!
Happy New Year!
Top 10 Glance stories of 2025
Top 10 Glance stories of 2025
Read More
Browse All Stories »